Goldman Sachs’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,394,100
| Closed | -$17.3M | – | 4672 |
|
|
2016
Q4 | $17.3M | Sell |
1,394,100
-1,968,082
| -59% | -$24.5M | ﹤0.01% | 1557 |
|
|
2016
Q3 | $46M | Buy |
3,362,182
+1,592,947
| +90% | +$21.8M | 0.01% | 1024 |
|
|
2016
Q2 | $13.1M | Buy |
1,769,235
+1,178,773
| +200% | +$8.71M | ﹤0.01% | 1613 |
|
|
2016
Q1 | $3.77M | Buy |
590,462
+206,616
| +54% | +$1.32M | ﹤0.01% | 2209 |
|
|
2015
Q4 | $2.4M | Sell |
383,846
-214,680
| -36% | -$1.34M | ﹤0.01% | 2426 |
|
|
2015
Q3 | $3.5M | Sell |
598,526
-201,952
| -25% | -$1.18M | ﹤0.01% | 2217 |
|
|
2015
Q2 | $6.62M | Buy |
800,478
+299,575
| +60% | +$2.48M | ﹤0.01% | 1907 |
|
|
2015
Q1 | $4.13M | Sell |
500,903
-338,145
| -40% | -$2.79M | ﹤0.01% | 2132 |
|
|
2014
Q4 | $5.76M | Sell |
839,048
-4,209
| -0.5% | -$28.9K | ﹤0.01% | 1903 |
|
|
2014
Q3 | $4.55M | Buy |
843,257
+351,794
| +72% | +$1.9M | ﹤0.01% | 2037 |
|
|
2014
Q2 | $3.13M | Buy |
491,463
+89,898
| +22% | +$573K | ﹤0.01% | 2280 |
|
|
2014
Q1 | $3.24M | Sell |
401,565
-517,781
| -56% | -$4.17M | ﹤0.01% | 2277 |
|
|
2013
Q4 | $6.27M | Sell |
919,346
-7,203,784
| -89% | -$49.1M | ﹤0.01% | 1839 |
|
|
2013
Q3 | $149M | Buy |
8,123,130
+1,554,560
| +24% | +$28.6M | 0.06% | 306 |
|
|
2013
Q2 | $115M | Buy |
+6,568,570
| New | +$115M | 0.04% | 365 |
|